Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Faculty who have authored publication Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer.

NameTitleDepartmentInstitution
Razelle Kurzrock MDCenter Associate Director, ProfessorMedicineMedical College of Wisconsin